Procedure for Stability Testing of Nanomedicines

1) Purpose

The purpose of this SOP is to establish a procedure for conducting stability testing for nanomedicines in compliance with relevant regulatory guidelines. This ensures that nanomedicines maintain their nanoscale properties, quality, safety, and efficacy throughout their shelf life.

2) Scope

This SOP applies to all personnel involved in the stability testing of nanomedicines, including formulation development, quality control, and regulatory affairs teams.

3) Responsibilities

Formulation Development Team: Responsible for developing nanomedicines and selecting suitable packaging materials.
Stability Study Team: Responsible for conducting stability studies according to approved protocols.
Regulatory Affairs Team: Responsible for ensuring compliance with regulatory requirements and submitting stability data to authorities.

4) Procedure

4.1 Protocol Development

4.1.1 Develop a stability testing protocol that includes parameters specific to nanomedicines, such as particle size distribution, zeta potential, encapsulation efficiency, and release profile.

4.1.2 Define storage conditions (e.g., room temperature, refrigerated)

“Unlocking the Secrets of Drug Development: Your Essential Guide to Preformulation of Chemical, Biological, and Botanical Drugs!”

4.2 Sample Preparation and Storage

4.2.1 Prepare samples in their final packaging for stability testing, ensuring consistency in formulation throughout the study.

4.2.2 Store samples under specified conditions, with continuous monitoring of environmental conditions.

4.3 Conducting Stability Tests

4.3.1 Perform stability tests at defined